Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy

MLA

Kristine M. Erlandson, et al. Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy. Mar. 2017. EBSCOhost, https://doi.org/10.1093/infdis/jix063.

APA

Kristine M. Erlandson, Susan L. Koletar, Ronald J. Ellis, Robert C. Kalayjian, Babafemi Taiwo, Kunling Wu, Frank J. Palella, & Katherine Tassiopoulos. (2017). Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy. https://doi.org/10.1093/infdis/jix063.

Chicago

Kristine M. Erlandson, Susan L. Koletar, Ronald J. Ellis, Robert C. Kalayjian, Babafemi Taiwo, Kunling Wu, Frank J. Palella, and Katherine Tassiopoulos. 2017. “Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy,” March. doi:10.1093/infdis/jix063.